Charles J. Kotzer

738 total citations
12 papers, 641 citations indexed

About

Charles J. Kotzer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Charles J. Kotzer has authored 12 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Physiology. Recurrent topics in Charles J. Kotzer's work include Receptor Mechanisms and Signaling (6 papers), Neuropeptides and Animal Physiology (4 papers) and Asthma and respiratory diseases (4 papers). Charles J. Kotzer is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Neuropeptides and Animal Physiology (4 papers) and Asthma and respiratory diseases (4 papers). Charles J. Kotzer collaborates with scholars based in United States and United Kingdom. Charles J. Kotzer's co-authors include Douglas W.P. Hay, David C. Underwood, Ruth R. Osborn, Steven Bochnowicz, Mark A. Luttmann, Edward F. Webb, Don E. Griswold, Jerry L. Adams, Donald C. Carpenter and John C. Lee and has published in prestigious journals such as Journal of Applied Physiology, Journal of Pharmacology and Experimental Therapeutics and Magnetic Resonance in Medicine.

In The Last Decade

Charles J. Kotzer

12 papers receiving 603 citations

Peers

Countries citing papers authored by Charles J. Kotzer

Since Specialization

Citations

This map shows the geographic impact of Charles J. Kotzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles J. Kotzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles J. Kotzer more than expected).

Fields of papers citing papers by Charles J. Kotzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles J. Kotzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles J. Kotzer. The network helps show where Charles J. Kotzer may publish in the future.

Co-authorship network of co-authors of Charles J. Kotzer

This figure shows the co-authorship network connecting the top 25 collaborators of Charles J. Kotzer. A scholar is included among the top collaborators of Charles J. Kotzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles J. Kotzer. Charles J. Kotzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Effects of airborne toxicants on pulmonary function and mitochondrial DNA damage in rodent lungs 2016 ·Mutagenesis ·William L. Rumsey, Brian Bolognese, (unknown), (unknown), Joseph P. Foley, (unknown), Charles J. Kotzer, Ruth R. Osborn, Patricia L. Podolin	10
2	Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases 2013 ·Journal of Pharmacology and Experimental Therapeutics ·M Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, (unknown), Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W.P. Hay, William L. Rumsey	64
3	The pre-clinical pharmacology of the inhaled muscarinic antagonist GSK573719 predicts once-daily clinical dosing 2011 ·European Respiratory Journal ·Dramane I. Lainé, Mark A. Luttmann, James J. Foley, (unknown), Charles J. Kotzer, M Salmon, William L. Rumsey	15
4	Serial MRI characterization of the functional and morphological changes in mouse lung in response to cardiac remodeling following myocardial infarction 2011 ·Magnetic Resonance in Medicine ·Hasan Alsaid, Weike Bao, (unknown), (unknown), David J. Figueroa, Stephen C. Lenhard, Charles J. Kotzer, Mark Burgert, Robert N. Willette, Victor A. Ferrari, Beat M. Jucker	5
5	Regional function-structure relationships in lungs of an elastase murine model of emphysema 2011 ·Journal of Applied Physiology ·Masaru Ishii, Kiarash Emami, Yi Xin, (unknown), Charles J. Kotzer, (unknown), (unknown), (unknown), Jianliang Zhu, Stephen Pickup, N. N. Kuzma, Stephen Kadlecek, Patricia L. Podolin, Rahim R. Rizi	12
6	A Noninvasive [99mTc]DTPA SPECT/CT Imaging Methodology as a Measure of Lung Permeability in a Guinea Pig Model of COPD 2010 ·Molecular Imaging and Biology ·(unknown), Charles J. Kotzer, Sokratis Makrogiannis, (unknown), Hyking Haley, Mary S. Barnette, (unknown)	12
7	Nonpeptide Tachykinin Receptor Antagonists. III. SB 235375, a Low Central Nervous System-Penetrant, Potent and Selective Neurokinin-3 Receptor Antagonist, Inhibits Citric Acid-Induced Cough and Airways Hyper-reactivity in Guinea Pigs 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Douglas W.P. Hay, Giuseppe Giardina, Don E. Griswold, David C. Underwood, Charles J. Kotzer, (unknown), W. M. Potts, Punam Sandhu, (unknown), James J. Foley, Dulcie B. Schmidt, Lenox D. Martin, David Kilian, Jeffrey J. Legos, Frank C. Barone, Mark A. Luttmann, Mario Grugni, Luca F. Raveglia, Henry M. Sarau	75
8	SB 239063, a Potent p38 MAP Kinase Inhibitor, Reduces Inflammatory Cytokine Production, Airways Eosinophil Infiltration, and Persistence 2000 ·Journal of Pharmacology and Experimental Therapeutics ·David C. Underwood, Ruth R. Osborn, Charles J. Kotzer, Jerry L. Adams, John C. Lee, Edward F. Webb, Donald C. Carpenter, Steven Bochnowicz, Heath C. Thomas, Douglas W.P. Hay, Don E. Griswold	216
9	The Antitussive Activity of δ-Opioid Receptor Stimulation in Guinea Pigs 2000 ·Journal of Pharmacology and Experimental Therapeutics ·Charles J. Kotzer, Douglas W.P. Hay, Giulio Dondio, Giuseppe Giardina, Paola Petrillo, David C. Underwood	27
10	The antitussive activity of delta-opioid receptor stimulation in guinea pigs. 2000 ·PubMed ·Charles J. Kotzer, Douglas W.P. Hay, Giulio Dondio, Giuseppe Giardina, Paola Petrillo, David C. Underwood	61
11	Antiasthmatic Activity of the Second-Generation Phosphodiesterase 4 (PDE4) Inhibitor SB 207499 (Ariflo) in the Guinea Pig 1998 ·Journal of Pharmacology and Experimental Therapeutics ·David C. Underwood, Steven Bochnowicz, Ruth R. Osborn, Charles J. Kotzer, Mark A. Luttmann, Douglas W.P. Hay, Peter D. Gorycki, S. Brøgger Christensen, Theodore J. Torphy	60
12	Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. 1994 ·Journal of Pharmacology and Experimental Therapeutics ·David C. Underwood, Charles J. Kotzer, Steven Bochnowicz, Ruth R. Osborn, Mark A. Luttmann, Douglas W.P. Hay, Theodore J. Torphy	84

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact